Mark Chilton

1.0k total citations
9 papers, 91 citations indexed

About

Mark Chilton is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Psychiatry and Mental health. According to data from OpenAlex, Mark Chilton has authored 9 papers receiving a total of 91 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 3 papers in Experimental and Cognitive Psychology and 3 papers in Psychiatry and Mental health. Recurrent topics in Mark Chilton's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers), Pharmacology and Obesity Treatment (2 papers) and Treatment of Major Depression (2 papers). Mark Chilton is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers), Pharmacology and Obesity Treatment (2 papers) and Treatment of Major Depression (2 papers). Mark Chilton collaborates with scholars based in United States, Australia and United Kingdom. Mark Chilton's co-authors include Thomas L. Schwartz, Nikhil Nihalani, Subhdeep Virk, Sahil Jindal, Patrice Carter, Melanie J. Davies, Kamlesh Khunti, Alison Dunkley, Laura J. Gray and Ayesha Rashid and has published in prestigious journals such as Australasian Journal of Paramedicine, Obesity Reviews and Diabetes Obesity and Metabolism.

In The Last Decade

Mark Chilton

7 papers receiving 83 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Chilton United States 6 29 26 24 16 14 9 91
Mahmood AminiLari Canada 7 16 0.6× 71 2.7× 58 2.4× 10 0.6× 28 2.0× 14 218
Simon Hjerrild Denmark 9 73 2.5× 48 1.8× 48 2.0× 20 1.3× 7 0.5× 20 309
Giuseppe Imperadore Italy 4 36 1.2× 33 1.3× 14 0.6× 20 1.3× 4 0.3× 11 137
Shen-Ing Liu Taiwan 5 52 1.8× 18 0.7× 39 1.6× 21 1.3× 5 0.4× 6 142
Laura Schaffner Gray United States 6 42 1.4× 16 0.6× 9 0.4× 36 2.3× 17 1.2× 8 163
Sepideh Pooyania Canada 8 60 2.1× 40 1.5× 7 0.3× 12 0.8× 6 0.4× 25 207
Wenqi Geng China 6 20 0.7× 17 0.7× 7 0.3× 29 1.8× 20 1.4× 20 108
Amani Alotaibi Saudi Arabia 4 28 1.0× 14 0.5× 10 0.4× 7 0.4× 8 0.6× 10 263
Erik Kelly United States 7 37 1.3× 11 0.4× 59 2.5× 13 0.8× 9 0.6× 10 299
Klara Suneson Sweden 6 33 1.1× 13 0.5× 71 3.0× 17 1.1× 3 0.2× 10 266

Countries citing papers authored by Mark Chilton

Since Specialization
Citations

This map shows the geographic impact of Mark Chilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Chilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Chilton more than expected).

Fields of papers citing papers by Mark Chilton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Chilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Chilton. The network helps show where Mark Chilton may publish in the future.

Co-authorship network of co-authors of Mark Chilton

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Chilton. A scholar is included among the top collaborators of Mark Chilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Chilton. Mark Chilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Chilton, Mark, Alison Dunkley, Patrice Carter, et al.. (2013). The effect of antiobesity drugs on waist circumference: a mixed treatment comparison. Diabetes Obesity and Metabolism. 16(3). 237–247. 15 indexed citations
2.
Schwartz, Thomas L., et al.. (2007). Modafinil Treatment for Fatigue Associated with Fibromyalgia. JCR Journal of Clinical Rheumatology. 13(1). 52–52. 16 indexed citations
3.
4.
Schwartz, Thomas L., Mark Chilton, & Alka Aneja. (2007). An eight-week, open-label, prospective case series of acamprosate calcium as monotherapy for patients with comorbid anxiety symptoms and alcohol misuse: an evaluation for alcohol sobriety and anxiolysis.. PubMed. 4(4). 19–20.
5.
Schwartz, Thomas L., et al.. (2006). The use of ramelteon for secondary insomnia due to mental illness. 13(12). 69–73.
6.
Schwartz, Thomas L., Nikhil Nihalani, Subhdeep Virk, Sahil Jindal, & Mark Chilton. (2004). Psychiatric medication‐induced obesity: treatment options. Obesity Reviews. 5(4). 233–238. 38 indexed citations
7.
Chilton, Mark. (2004). A Brief Analysis of Trends in Prehospital Care Services and a Vision for the Future. Australasian Journal of Paramedicine. 2. 1–6. 7 indexed citations
9.
Chilton, Mark, et al.. (1995). OAM Methodology Conference II Report: WORKING GROUPS, RESEARCH PRESENTATIONS. PubMed. 1(3). 18–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026